▶ 調査レポート

分子診断及びNATの世界市場 2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global Molecular Diagnostics and NAT Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。分子診断及びNATの世界市場 2020年:企業別、地域別、種類・用途別 / Global Molecular Diagnostics and NAT Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / D005-00697資料のイメージです。• レポートコード:D005-00697
• 出版社/出版日:GlobalInfoResearch / 2020年5月29日
• レポート形態:英文、PDF、100ページ
• 納品方法:Eメール
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥365,400 (USD3,480)▷ お問い合わせ
  Multi User¥548,100 (USD5,220)▷ お問い合わせ
  Corporate User¥730,800 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、分子診断及びNATの世界市場を広く調査・分析し、今後の市場展望をまとめております。分子診断及びNATの種類別市場規模(増幅技術、増幅遺伝子検出技術、DNAおよびオリゴヌクレオチドマイクロアレイ、遺伝子配列決定)、用途別市場規模(病院および診療所、研究所、診断センター)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Roche、GenMark、Biomerieux、Abbott、Agilent、BD、AutoGenomics、Thermo Fisher Scientific、Qiagen、Siemens Healthcare
・地域別グローバル市場分析 2015年-2020年
・分子診断及びNATの北米市場(アメリカ、カナダ、メキシコ)
・分子診断及びNATのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・分子診断及びNATのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・分子診断及びNATの南米市場(ブラジル、アルゼンチン)
・分子診断及びNATの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:増幅技術、増幅遺伝子検出技術、DNAおよびオリゴヌクレオチドマイクロアレイ、遺伝子配列決定
・用途別分析:病院および診療所、研究所、診断センター
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Molecular Diagnostics and NAT market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Molecular Diagnostics and NAT market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Molecular Diagnostics and NAT market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Molecular Diagnostics and NAT market has been segmented into:
Amplification Technologies
Amplified Gene Detection Technologies
DNA And Oligonucleotide Microarrays
Gene Sequencing

By Application, Molecular Diagnostics and NAT has been segmented into:
Hospitals and Clinics
Research Institutes
Diagnostic Centers

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Molecular Diagnostics and NAT market presented in the report. This section sheds light on the sales growth of different regional and country-level Molecular Diagnostics and NAT markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Molecular Diagnostics and NAT market.

The report offers in-depth assessment of the growth and other aspects of the Molecular Diagnostics and NAT market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Molecular Diagnostics and NAT Market Share Analysis
Molecular Diagnostics and NAT competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Molecular Diagnostics and NAT sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Molecular Diagnostics and NAT sales, revenue and market share for each player covered in this report.

The major players covered in Molecular Diagnostics and NAT are:
Roche
GenMark
Biomerieux
Abbott
Agilent
BD
AutoGenomics
Thermo Fisher Scientific
Qiagen
Siemens Healthcare

レポート目次

Table of Contents

1 Molecular Diagnostics and NAT Market Overview
1.1 Product Overview and Scope of Molecular Diagnostics and NAT
1.2 Classification of Molecular Diagnostics and NAT by Type
1.2.1 Global Molecular Diagnostics and NAT Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Molecular Diagnostics and NAT Revenue Market Share by Type in 2019
1.2.3 Amplification Technologies
1.2.4 Amplified Gene Detection Technologies
1.2.5 DNA And Oligonucleotide Microarrays
1.2.6 Gene Sequencing
1.3 Global Molecular Diagnostics and NAT Market by Application
1.3.1 Overview: Global Molecular Diagnostics and NAT Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals and Clinics
1.3.3 Research Institutes
1.3.4 Diagnostic Centers
1.4 Global Molecular Diagnostics and NAT Market by Regions
1.4.1 Global Molecular Diagnostics and NAT Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Molecular Diagnostics and NAT (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Molecular Diagnostics and NAT Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Molecular Diagnostics and NAT Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Molecular Diagnostics and NAT Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Molecular Diagnostics and NAT Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Molecular Diagnostics and NAT Status and Prospect (2015-2025)
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2018-2019)
2.2 GenMark
2.2.1 GenMark Details
2.2.2 GenMark Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 GenMark SWOT Analysis
2.2.4 GenMark Product and Services
2.2.5 GenMark Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2018-2019)
2.3 Biomerieux
2.3.1 Biomerieux Details
2.3.2 Biomerieux Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Biomerieux SWOT Analysis
2.3.4 Biomerieux Product and Services
2.3.5 Biomerieux Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2018-2019)
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Abbott SWOT Analysis
2.4.4 Abbott Product and Services
2.4.5 Abbott Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2018-2019)
2.5 Agilent
2.5.1 Agilent Details
2.5.2 Agilent Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Agilent SWOT Analysis
2.5.4 Agilent Product and Services
2.5.5 Agilent Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2018-2019)
2.6 BD
2.6.1 BD Details
2.6.2 BD Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 BD SWOT Analysis
2.6.4 BD Product and Services
2.6.5 BD Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2018-2019)
2.7 AutoGenomics
2.7.1 AutoGenomics Details
2.7.2 AutoGenomics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 AutoGenomics SWOT Analysis
2.7.4 AutoGenomics Product and Services
2.7.5 AutoGenomics Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2018-2019)
2.8 Thermo Fisher Scientific
2.8.1 Thermo Fisher Scientific Details
2.8.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Thermo Fisher Scientific SWOT Analysis
2.8.4 Thermo Fisher Scientific Product and Services
2.8.5 Thermo Fisher Scientific Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2018-2019)
2.9 Qiagen
2.9.1 Qiagen Details
2.9.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Qiagen SWOT Analysis
2.9.4 Qiagen Product and Services
2.9.5 Qiagen Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2018-2019)
2.10 Siemens Healthcare
2.10.1 Siemens Healthcare Details
2.10.2 Siemens Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Siemens Healthcare SWOT Analysis
2.10.4 Siemens Healthcare Product and Services
2.10.5 Siemens Healthcare Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Molecular Diagnostics and NAT Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Molecular Diagnostics and NAT Players Market Share
3.2.2 Top 10 Molecular Diagnostics and NAT Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Molecular Diagnostics and NAT Revenue and Market Share by Regions
4.2 North America Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
4.3 Europe Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
4.5 South America Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
5 North America Molecular Diagnostics and NAT Revenue by Countries
5.1 North America Molecular Diagnostics and NAT Revenue by Countries (2015-2020)
5.2 USA Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
5.3 Canada Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
5.4 Mexico Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
6 Europe Molecular Diagnostics and NAT Revenue by Countries
6.1 Europe Molecular Diagnostics and NAT Revenue by Countries (2015-2020)
6.2 Germany Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
6.3 UK Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
6.4 France Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
6.5 Russia Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
6.6 Italy Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Molecular Diagnostics and NAT Revenue by Countries
7.1 Asia-Pacific Molecular Diagnostics and NAT Revenue by Countries (2015-2020)
7.2 China Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
7.3 Japan Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
7.4 Korea Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
7.5 India Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
8 South America Molecular Diagnostics and NAT Revenue by Countries
8.1 South America Molecular Diagnostics and NAT Revenue by Countries (2015-2020)
8.2 Brazil Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
8.3 Argentina Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Molecular Diagnostics and NAT by Countries
9.1 Middle East & Africa Molecular Diagnostics and NAT Revenue by Countries (2015-2020)
9.2 Saudi Arabia Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
9.3 UAE Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
9.4 Egypt Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
9.5 South Africa Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Molecular Diagnostics and NAT Revenue and Market Share by Type (2015-2020)
10.2 Global Molecular Diagnostics and NAT Market Forecast by Type (2019-2024)
10.3 Amplification Technologies Revenue Growth Rate (2015-2025)
10.4 Amplified Gene Detection Technologies Revenue Growth Rate (2015-2025)
10.5 DNA And Oligonucleotide Microarrays Revenue Growth Rate (2015-2025)
10.6 Gene Sequencing Revenue Growth Rate (2015-2025)
11 Global Molecular Diagnostics and NAT Market Segment by Application
11.1 Global Molecular Diagnostics and NAT Revenue Market Share by Application (2015-2020)
11.2 Molecular Diagnostics and NAT Market Forecast by Application (2019-2024)
11.3 Hospitals and Clinics Revenue Growth (2015-2020)
11.4 Research Institutes Revenue Growth (2015-2020)
11.5 Diagnostic Centers Revenue Growth (2015-2020)
12 Global Molecular Diagnostics and NAT Market Size Forecast (2021-2025)
12.1 Global Molecular Diagnostics and NAT Market Size Forecast (2021-2025)
12.2 Global Molecular Diagnostics and NAT Market Forecast by Regions (2021-2025)
12.3 North America Molecular Diagnostics and NAT Revenue Market Forecast (2021-2025)
12.4 Europe Molecular Diagnostics and NAT Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Molecular Diagnostics and NAT Revenue Market Forecast (2021-2025)
12.6 South America Molecular Diagnostics and NAT Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Molecular Diagnostics and NAT Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Molecular Diagnostics and NAT Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Molecular Diagnostics and NAT by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Molecular Diagnostics and NAT Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Molecular Diagnostics and NAT Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Roche Corporate Information, Location and Competitors
Table 6. Roche Molecular Diagnostics and NAT Major Business
Table 7. Roche Molecular Diagnostics and NAT Total Revenue (USD Million) (2017-2018)
Table 8. Roche SWOT Analysis
Table 9. Roche Molecular Diagnostics and NAT Product and Solutions
Table 10. Roche Molecular Diagnostics and NAT Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. GenMark Corporate Information, Location and Competitors
Table 12. GenMark Molecular Diagnostics and NAT Major Business
Table 13. GenMark Molecular Diagnostics and NAT Total Revenue (USD Million) (2018-2019)
Table 14. GenMark SWOT Analysis
Table 15. GenMark Molecular Diagnostics and NAT Product and Solutions
Table 16. GenMark Molecular Diagnostics and NAT Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Biomerieux Corporate Information, Location and Competitors
Table 18. Biomerieux Molecular Diagnostics and NAT Major Business
Table 19. Biomerieux Molecular Diagnostics and NAT Total Revenue (USD Million) (2017-2018)
Table 20. Biomerieux SWOT Analysis
Table 21. Biomerieux Molecular Diagnostics and NAT Product and Solutions
Table 22. Biomerieux Molecular Diagnostics and NAT Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Abbott Corporate Information, Location and Competitors
Table 24. Abbott Molecular Diagnostics and NAT Major Business
Table 25. Abbott Molecular Diagnostics and NAT Total Revenue (USD Million) (2017-2018)
Table 26. Abbott SWOT Analysis
Table 27. Abbott Molecular Diagnostics and NAT Product and Solutions
Table 28. Abbott Molecular Diagnostics and NAT Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Agilent Corporate Information, Location and Competitors
Table 30. Agilent Molecular Diagnostics and NAT Major Business
Table 31. Agilent Molecular Diagnostics and NAT Total Revenue (USD Million) (2017-2018)
Table 32. Agilent SWOT Analysis
Table 33. Agilent Molecular Diagnostics and NAT Product and Solutions
Table 34. Agilent Molecular Diagnostics and NAT Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. BD Corporate Information, Location and Competitors
Table 36. BD Molecular Diagnostics and NAT Major Business
Table 37. BD Molecular Diagnostics and NAT Total Revenue (USD Million) (2017-2018)
Table 38. BD SWOT Analysis
Table 39. BD Molecular Diagnostics and NAT Product and Solutions
Table 40. BD Molecular Diagnostics and NAT Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. AutoGenomics Corporate Information, Location and Competitors
Table 42. AutoGenomics Molecular Diagnostics and NAT Major Business
Table 43. AutoGenomics Molecular Diagnostics and NAT Total Revenue (USD Million) (2017-2018)
Table 44. AutoGenomics SWOT Analysis
Table 45. AutoGenomics Molecular Diagnostics and NAT Product and Solutions
Table 46. AutoGenomics Molecular Diagnostics and NAT Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 48. Thermo Fisher Scientific Molecular Diagnostics and NAT Major Business
Table 49. Thermo Fisher Scientific Molecular Diagnostics and NAT Total Revenue (USD Million) (2017-2018)
Table 50. Thermo Fisher Scientific SWOT Analysis
Table 51. Thermo Fisher Scientific Molecular Diagnostics and NAT Product and Solutions
Table 52. Thermo Fisher Scientific Molecular Diagnostics and NAT Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Qiagen Corporate Information, Location and Competitors
Table 54. Qiagen Molecular Diagnostics and NAT Major Business
Table 55. Qiagen Molecular Diagnostics and NAT Total Revenue (USD Million) (2017-2018)
Table 56. Qiagen SWOT Analysis
Table 57. Qiagen Molecular Diagnostics and NAT Product and Solutions
Table 58. Qiagen Molecular Diagnostics and NAT Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Siemens Healthcare Corporate Information, Location and Competitors
Table 60. Siemens Healthcare Molecular Diagnostics and NAT Major Business
Table 61. Siemens Healthcare Molecular Diagnostics and NAT Total Revenue (USD Million) (2017-2018)
Table 62. Siemens Healthcare SWOT Analysis
Table 63. Siemens Healthcare Molecular Diagnostics and NAT Product and Solutions
Table 64. Siemens Healthcare Molecular Diagnostics and NAT Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Molecular Diagnostics and NAT Revenue (Million USD) by Players (2015-2020)
Table 66. Global Molecular Diagnostics and NAT Revenue Share by Players (2015-2020)
Table 67. Global Molecular Diagnostics and NAT Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Molecular Diagnostics and NAT Revenue Market Share by Regions (2015-2020)
Table 69. North America Molecular Diagnostics and NAT Revenue by Countries (2015-2020)
Table 70. North America Molecular Diagnostics and NAT Revenue Market Share by Countries (2015-2020)
Table 71. Europe Molecular Diagnostics and NAT Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Molecular Diagnostics and NAT Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Molecular Diagnostics and NAT Revenue by Countries (2015-2020)
Table 74. South America Molecular Diagnostics and NAT Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Molecular Diagnostics and NAT Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Molecular Diagnostics and NAT Revenue Market Share by Countries (2015-2020)
Table 77. Global Molecular Diagnostics and NAT Revenue (Million USD) by Type (2015-2020)
Table 78. Global Molecular Diagnostics and NAT Revenue Share by Type (2015-2020)
Table 79. Global Molecular Diagnostics and NAT Revenue Forecast by Type (2021-2025)
Table 80. Global Molecular Diagnostics and NAT Revenue by Application (2015-2020)
Table 81. Global Molecular Diagnostics and NAT Revenue Share by Application (2015-2020)
Table 82. Global Molecular Diagnostics and NAT Revenue Forecast by Application (2021-2025)
Table 83. Global Molecular Diagnostics and NAT Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Molecular Diagnostics and NAT Picture
Figure 2. Global Molecular Diagnostics and NAT Revenue Market Share by Type in 2019
Figure 3. Amplification Technologies Picture
Figure 4. Amplified Gene Detection Technologies Picture
Figure 5. DNA And Oligonucleotide Microarrays Picture
Figure 6. Gene Sequencing Picture
Figure 7. Molecular Diagnostics and NAT Revenue Market Share by Application in 2019
Figure 8. Hospitals and Clinics Picture
Figure 9. Research Institutes Picture
Figure 10. Diagnostic Centers Picture
Figure 11. Global Molecular Diagnostics and NAT Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Molecular Diagnostics and NAT Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Molecular Diagnostics and NAT Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Molecular Diagnostics and NAT Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Molecular Diagnostics and NAT Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Molecular Diagnostics and NAT Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Molecular Diagnostics and NAT Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Molecular Diagnostics and NAT Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Molecular Diagnostics and NAT Revenue Market Share in 2019
Figure 20. Global Top 10 Players Molecular Diagnostics and NAT Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Molecular Diagnostics and NAT Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Molecular Diagnostics and NAT Revenue Market Share by Regions (2015-2020)
Figure 24. Global Molecular Diagnostics and NAT Revenue Market Share by Regions in 2018
Figure 25. North America Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
Figure 26. Europe Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
Figure 28. South America Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
Figure 30. North America Molecular Diagnostics and NAT Revenue Market Share by Countries (2015-2020)
Figure 31. North America Molecular Diagnostics and NAT Revenue Market Share by Countries in 2019
Figure 32. USA Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
Figure 33. Canada Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
Figure 35. Europe Molecular Diagnostics and NAT Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Molecular Diagnostics and NAT Revenue Market Share by Countries in 2019
Figure 37. Germany Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
Figure 38. UK Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
Figure 39. France Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
Figure 40. Russia Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
Figure 41. Italy Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Molecular Diagnostics and NAT Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Molecular Diagnostics and NAT Revenue Market Share by Countries in 2019
Figure 44. China Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
Figure 45. Japan Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
Figure 46. Korea Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
Figure 47. India Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
Figure 49. South America Molecular Diagnostics and NAT Revenue Market Share by Countries (2015-2020)
Figure 50. South America Molecular Diagnostics and NAT Revenue Market Share by Countries in 2019
Figure 51. Brazil Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Molecular Diagnostics and NAT Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Molecular Diagnostics and NAT Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
Figure 56. UAE Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
Figure 59. Global Molecular Diagnostics and NAT Revenue Share by Type (2015-2020)
Figure 60. Global Molecular Diagnostics and NAT Revenue Share by Type in 2019
Figure 61. Global Molecular Diagnostics and NAT Market Share Forecast by Type (2021-2025)
Figure 62. Global Amplification Technologies Revenue Growth Rate (2015-2020)
Figure 63. Global Amplified Gene Detection Technologies Revenue Growth Rate (2015-2020)
Figure 64. Global DNA And Oligonucleotide Microarrays Revenue Growth Rate (2015-2020)
Figure 65. Global Gene Sequencing Revenue Growth Rate (2015-2020)
Figure 66. Global Molecular Diagnostics and NAT Revenue Share by Application (2015-2020)
Figure 67. Global Molecular Diagnostics and NAT Revenue Share by Application in 2019
Figure 68. Global Molecular Diagnostics and NAT Market Share Forecast by Application (2021-2025)
Figure 69. Global Hospitals and Clinics Revenue Growth Rate (2015-2020)
Figure 70. Global Research Institutes Revenue Growth Rate (2015-2020)
Figure 71. Global Diagnostic Centers Revenue Growth Rate (2015-2020)
Figure 72. Global Molecular Diagnostics and NAT Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Molecular Diagnostics and NAT Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Molecular Diagnostics and NAT Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Molecular Diagnostics and NAT Revenue Market Forecast (2021-2025)
Figure 76. Europe Molecular Diagnostics and NAT Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Molecular Diagnostics and NAT Revenue Market Forecast (2021-2025)
Figure 78. South America Molecular Diagnostics and NAT Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Molecular Diagnostics and NAT Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel